EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis

Vinton W T Cheng iD, Richard Heywood, Rasheed Zakaria, Rebecca Burger, Kieran Zucker, Siddarth Kannan, Muhammad Alifian Remifta Putra, Amanda Fitzpatrick iD, Gary Doherty, Paul Sanghera, Michael D Jenkinson, Carlo Palmieri

Neuro-Oncology · 05.12.2024 · 26 (12) · 2193-2207

DOI: 10.1093/neuonc/noae140 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Neuro-Oncology, online erschienen am 02.08.2024. Verfasst von Vinton W T Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Meningeal Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies have challenged the notion that patients with brain metastasis (BM) or leptomeningeal metastasis (LM) should be excluded from systemic therapy clinical trials. This scoping study summarizes the BM/LM clinical studies published between 2010 and 2023.

Methods

MEDLINE, CINAHL, CAB Abstracts, PsycINFO, Cochrane Library, HINARI, International Pharmaceutical Abstracts, PubMed, Scopus, Web of Science, and EMBASE electronic databases were searched on June 21, 2021. An updated search was performed on February 21, 2023. Eligible studies investigated a therapeutic intervention in solid tumor patients with BM and/or LM and reported a patient outcome. Extracted study-level data, including study type, publication date, geographical location, number of BM/LM patients in the study, primary tumor type, and type of therapeutic intervention, were collected.

Results

4921 unique studies were eligible for analysis. The key finding is that BM/LM clinical research is expanding globally, both in observational studies and clinical trials. Despite the shift over time toward a higher proportion of systemic therapy trials, the majority still do not include patients with symptomatic disease and lack reporting of BM/LM-specific endpoints. Globally, there has been a trend to more international collaboration in BM/LM clinical studies.

Conclusions

Our analysis of the BM/LM literature charts the evolving landscape of studies involving this previously excluded population. Given the increasing clinical research activity, particularly involving late-stage systemic therapy trials, it is imperative that due consideration is given to the intracranial activity of new investigational agents. Wider adoption of standardized reporting of intracranial-specific endpoints will facilitate the evaluation of relative intracranial efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningeal NeoplasmsBrain NeoplasmsHumansClinical Trials as Topic

Stichwörter der Autor:innen

brain metastasisintracranial endpointsleptomeningeal metastasisscoping review

Autor:innen und Institutionen

  • Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK.
  • Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Department of Oncology, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Imperial College Healthcare NHS Trust, London, UK.
  • Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.

ORCID-Profile: Vinton W T Cheng, Amanda Fitzpatrick

Förderung

  • National Institute for Health and Care Research

Zitieren

APA

Cheng, V. W. T., Heywood, R., Zakaria, R., Burger, R., Zucker, K., Kannan, S., Putra, M. A. R., Fitzpatrick, A., Doherty, G., Sanghera, P., Jenkinson, M. D., & Palmieri, C. (2024). BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis. Neuro-Oncology, 26(12), 2193-2207. https://doi.org/10.1093/neuonc/noae140

Vancouver

Cheng VWT, Heywood R, Zakaria R, Burger R, Zucker K, Kannan S, et al. BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis. Neuro-Oncology. 2024;26(12):2193-2207. doi:10.1093/neuonc/noae140

BibTeX
@article{Cheng2024,
  author = {Cheng, Vinton W T and Heywood, Richard and Zakaria, Rasheed and Burger, Rebecca and Zucker, Kieran and Kannan, Siddarth and Putra, Muhammad Alifian Remifta and Fitzpatrick, Amanda and Doherty, Gary and Sanghera, Paul and Jenkinson, Michael D and Palmieri, Carlo},
  title = {BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {12},
  pages = {2193--2207},
  doi = {10.1093/neuonc/noae140}
}
Kostenlos starten →